Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $67.40 USD
Change Today 0.00 / 0.00%
Volume 500.3K
LCI On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:04 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - lannett co inc (LCI)

Name (Connections)Board RelationshipsTitleKey Developments
David Drabik 5 RelationshipsIndependent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee, Member of Strategic Planning Committee and Member of Compensation CommitteeLannett Co. Inc. announced delayed annual 10-K filing
09/13/07
Paul Taveira 5 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Governance Committee and Member of Audit CommitteeLannett Co. Inc. Reports Preliminary Unaudited Earnings Results for the Full Year Ended June 30, 2007; Restates Earnings Results for the First Nine Months of Fiscal 2007
10/1/07
James Maher 5 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee 

Compensation Committee* - lannett co inc (LCI)

Name (Connections)Board RelationshipsTitle
David Drabik 5 RelationshipsIndependent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee, Member of Strategic Planning Committee and Member of Compensation Committee
James Maher 5 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
Paul Taveira 5 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Governance Committee and Member of Audit Committee
LCI Compensation vs. Industry
539.0K
436.8K
Chief Executive Officer
317.0K
309.3K
Chief Financial Officer
346.0K
338.4K
Chief Operating Officer
Share price activity for LANNETT CO INC (LCI)
52 Week Price Performance
LCI
Industry Average

Nominating Committee* - lannett co inc (LCI)

Name (Connections)Board RelationshipsTitleKey Developments
David Drabik 5 RelationshipsIndependent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee, Member of Strategic Planning Committee and Member of Compensation CommitteeLannett Company, Inc. Names Michael J. Bogda as President
12/5/14
Paul Taveira 5 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Governance Committee and Member of Audit CommitteeLannett Company, Inc. Announces Retirement of Ernest J. Sabo as Vice President of Regulatory Affairs and Chief Compliance Officer, Effective January 2, 2015
11/17/14
James Maher 5 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance CommitteeLannett Company, Inc. Appoints James Maher to its Board of Directors, Effective July 1, 2013
06/3/13

Corporate Governance Committee* - lannett co inc (LCI)

Name (Connections)Board RelationshipsTitle
David Drabik 5 RelationshipsIndependent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee, Member of Strategic Planning Committee and Member of Compensation Committee
James Maher 5 RelationshipsIndependent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
Paul Taveira 5 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Governance Committee and Member of Audit Committee
LCI and Competitor
Insiders vs. External
Board
17%
83%
Lannett Company, Inc.
17%
83%
Covisint Corporation
17%
83%
ANI Pharmaceuticals, Inc.
43%
57%
Vista Pharmaceuticals Limited
25%
75%
Pernix Therapeutics Holdings, Inc.
14%
86%
Sagent Pharmaceuticals, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LCI:US $67.40 USD 0.00

LCI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ANI Pharmaceuticals Inc $70.26 USD -1.52
Covisint Corp $2.00 USD 0.00
Pernix Therapeutics Holdings Inc $7.09 USD -0.24
Sagent Pharmaceuticals Inc $25.20 USD -0.40
Vista Pharmaceuticals Ltd 18.95 INR -0.35
View Industry Companies
 

Industry Analysis

LCI

Industry Average

Valuation LCI Industry Range
Price/Earnings 19.7x
Price/Sales 6.5x
Price/Book 6.3x
Price/Cash Flow 19.1x
TEV/Sales 6.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANNETT CO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.